422 related articles for article (PubMed ID: 32535589)
1. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.
Ju JK; Cho YN; Park KJ; Kwak HD; Jin HM; Park SY; Kim HS; Kee SJ; Park YW
J Innate Immun; 2020; 12(5):422-434. PubMed ID: 32535589
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
[TBL] [Abstract][Full Text] [Related]
3. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
[TBL] [Abstract][Full Text] [Related]
4. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.
Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW
J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases.
Tominaga K; Yamagiwa S; Setsu T; Kimura N; Honda H; Kamimura H; Honda Y; Takamura M; Yokoyama J; Suzuki K; Wakai T; Terai S
Biomed Res; 2017; 38(2):111-121. PubMed ID: 28442662
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution and enhanced osteoclastogenesis of mucosal-associated invariant T cells in gouty arthritis.
Cho YN; Jeong HS; Park KJ; Kim HS; Kim EH; Jin HM; Jung HJ; Ju JK; Choi SE; Kang JH; Park DJ; Kim TJ; Lee SS; Kee SJ; Park YW
Rheumatology (Oxford); 2020 Aug; 59(8):2124-2134. PubMed ID: 32087015
[TBL] [Abstract][Full Text] [Related]
7. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
8. Mucosal-associated invariant T cells display both pathogenic and protective roles in patients with inflammatory bowel diseases.
Wei L; Chen Z; Lv Q
Amino Acids; 2023 Dec; 55(12):1819-1827. PubMed ID: 37819474
[TBL] [Abstract][Full Text] [Related]
9. CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.
Chen Z; Liu S; He C; Sun J; Wang L; Chen H; Zhang F
Front Immunol; 2021; 12():578548. PubMed ID: 33815355
[No Abstract] [Full Text] [Related]
10. Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease.
Yasutomi Y; Chiba A; Haga K; Murayama G; Makiyama A; Kuga T; Watanabe M; Okamoto R; Nagahara A; Nagaishi T; Miyake S
Cell Mol Gastroenterol Hepatol; 2022; 13(1):81-93. PubMed ID: 34461283
[TBL] [Abstract][Full Text] [Related]
11. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.
Ling L; Lin Y; Zheng W; Hong S; Tang X; Zhao P; Li M; Ni J; Li C; Wang L; Jiang Y
Sci Rep; 2016 Feb; 6():20358. PubMed ID: 26837580
[TBL] [Abstract][Full Text] [Related]
12. Mucosal-Associated Invariant T Cells Develop an Innate-Like Transcriptomic Program in Anti-mycobacterial Responses.
Sharma M; Zhang S; Niu L; Lewinsohn DM; Zhang X; Huang S
Front Immunol; 2020; 11():1136. PubMed ID: 32582206
[TBL] [Abstract][Full Text] [Related]
13. Activation and increased production of interleukin-17 and tumour necrosis factor-α of mucosal-associated invariant T cells in patients with periodontitis.
Kim OS; Park KJ; Jin HM; Cho YN; Kim YS; Kwon SH; Koh JT; Ju JK; Kee SJ; Park YW
J Clin Periodontol; 2022 Jul; 49(7):706-716. PubMed ID: 35569027
[TBL] [Abstract][Full Text] [Related]
14. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
Hiejima E; Kawai T; Nakase H; Tsuruyama T; Morimoto T; Yasumi T; Taga T; Kanegane H; Hori M; Ohmori K; Higuchi T; Matsuura M; Yoshino T; Ikeuchi H; Kawada K; Sakai Y; Kitazume MT; Hisamatsu T; Chiba T; Nishikomori R; Heike T
Inflamm Bowel Dis; 2015 Jul; 21(7):1529-40. PubMed ID: 25946569
[TBL] [Abstract][Full Text] [Related]
15. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
16. The Immune Modulating Properties of Mucosal-Associated Invariant T Cells.
Ioannidis M; Cerundolo V; Salio M
Front Immunol; 2020; 11():1556. PubMed ID: 32903532
[TBL] [Abstract][Full Text] [Related]
17. Activation and Impaired Tumor Necrosis Factor-α Production of Circulating Mucosal-Associated Invariant T Cells in Patients with Trauma.
Jo YG; Jin HM; Cho YN; Kim JC; Kee SJ; Park YW
J Innate Immun; 2019; 11(6):506-515. PubMed ID: 31085907
[TBL] [Abstract][Full Text] [Related]
18. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
Zumwalde NA; Haag JD; Gould MN; Gumperz JE
Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
[TBL] [Abstract][Full Text] [Related]
19. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
[TBL] [Abstract][Full Text] [Related]
20. Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus.
Chiba A; Tamura N; Yoshikiyo K; Murayama G; Kitagaichi M; Yamaji K; Takasaki Y; Miyake S
Arthritis Res Ther; 2017 Mar; 19(1):58. PubMed ID: 28288675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
